Novartis Lamisil TV Ad Cited For “Dominant,” “Distracting” Digger Character
Executive Summary
FDA is objecting to the sequence in which Novartis presents the qualifying and efficacy information for its anti-fungal Lamisil in the company's TV ads
You may also be interested in...
Novartis Sales Growth Strategy Is DTC Ads, “Cleverly Crafted” Phase IVs
Novartis is considering expanded use of direct-to-consumer ads based on the positive results of DTC campaigns for Elidel, Zelnorm and Lamisil
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011